文献速递围术期管理与 ERAS

血管内治疗时代原发性与再次颈动脉内膜切除术的风险比较

Risks Associated With Primary and Redo Carotid Endarterectomy in the Endovascular Era.
PubMed 文献 · JAMA Surg · 2018-01-01

无症状患者再次CEA的30天卒中、死亡及卒中或死亡风险显著高于原发性CEA,而有症状患者两者结局相似。

要点

  • 无症状患者再次CEA的30天卒中风险是原发CEA的2.82倍(OR 2.82,95%CI 1.69-4.71)。
  • 无症状患者再次CEA的30天死亡风险是原发CEA的2.15倍(OR 2.15,95%CI 1.21-3.79)。
  • 有症状患者再次CEA与原发CEA的30天卒中、死亡及卒中或死亡风险无显著差异。

核心结论

  • 再次CEA与原发CEA的结局均在颈动脉血运重建专业指南范围内。
  • 无症状患者再次CEA相比原发CEA,卒中风险增加2.8倍,死亡风险增加2.2倍。
  • 有症状患者再次CEA与原发CEA的结局无显著差异。

研究设计与样本

  • 研究为前瞻性队列的回顾性分析,数据来自血管外科学会血管质量倡议(VQI)。
  • 纳入2003年1月1日至2016年4月30日期间美国学术和社区医院连续接受原发或再次CEA的症状性或无症状颈动脉狭窄患者。
  • 原发CEA中位年龄71岁,女性39.5%;再次CEA中位年龄71岁,女性42.2%。

主要发现

  • 30天卒中发生率:无症状患者原发CEA 0.7% vs 再次CEA 1.9%(P < .001);有症状患者1.5% vs 1.4%(P = .77);总体0.9% vs 1.8%(P = .002)。
  • 围手术期心肌梗死发生率0.8% vs 1.3%(P = .09),死亡0.6% vs 1.4%(P = .003),卒中或死亡1.5% vs 2.6%(P = .001)。
  • 无症状患者风险校正后30天卒中(OR 2.82;95%CI 1.69-4.71;P < .001)、死亡(OR 2.15;95%CI 1.21-3.79;P = .009)、卒中或死亡(OR 2.06;95%CI 1.32-3.23;P = .002)再次CEA均高于原发CEA。
  • 有症状患者风险校正后30天卒中(OR 0.79;95%CI 0.33-1.95;P = .62)、死亡(OR 1.32;95%CI 0.53-3.26;P = .55)、卒中或死亡(OR 0.85;95%CI 0.39-1.82;P = .68)两者相似。
  • 无症状患者1年卒中或死亡再次CEA更高(HR 1.36;95%CI 1.08-1.69;P = .009),有症状患者相似(HR 0.94;95%CI 0.67-1.31;P = .71)。

临床怎么用

  • 对于无症状颈动脉狭窄患者,选择再次CEA时应充分告知其卒中及死亡风险显著高于原发CEA。
  • 对于有症状患者,再次CEA与原发CEA风险相当,可与患者共同决策。
  • 再次CEA与原发CEA的结局均在指南范围内,但需根据症状状态个体化评估风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Clinical experience suggests worse outcomes for redo carotid endarterectomy (CEA) relative to primary CEA. Objective quantification of the excess risk attributable to redo CEA in this era of proliferating endovascular therapy remains to be determined. OBJECTIVE: To evaluate the risks of redo CEA relative to primary CEA. DESIGN, SETTING, AND PARTICIPANTS: This study was a retrospective analysis of a prospective cohort of patients maintained by the Society for Vascular Surgery in the Vascular Quality Initiative between January 1, 2003, and April 30, 2016. The setting was consecutive patients from academic and community hospitals across the United States. Participants were patients who underwent primary CEA or redo CEA for symptomatic or asymptomatic carotid stenosis. EXPOSURES: Primary CEA and redo CEA. MAIN OUTCOMES AND MEASURES: Stroke, death, myocardial infarction, stroke or death, and stroke, death, or myocardial infarction at 30 days and 1 year. RESULTS: There were 64 118 CEAs recorded, including 62 749 primary CEAs (97.9%) (median age, 71 years; 39.5% female) and 1369 redo CEAs (2.1%) (median age, 71 years; 42.2% female). Comparing primary CEA vs redo CEA, the incidence of 30-day stroke was 0.7% vs 1.9% (P < .001) for asymptomatic patients and 1.5% vs 1.4% (P = .77) for symptomatic patients for an overall 0.9% vs 1.8% (P = .002). Incidences were 0.8% vs 1.3% (P = .09) for perioperative myocardial infarction, 0.6% vs 1.4% (P = .003) for death, and 1.5% vs 2.6% (P = .001) for stroke or death. Risk-adjusted 30-day stroke (odds ratio [OR], 2.82; 95% CI, 1.69-4.71; P < .001), death (OR, 2.15; 95% CI, 1.21-3.79; P = .009), and stroke or death (OR, 2.06; 95% CI, 1.32-3.23; P = .002) were higher for redo CEA compared with primary CEA among asymptomatic patients but were similar among symptomatic patients for stroke (OR, 0.79; 95% CI, 0.33-1.95; P = .62), death (OR, 1.32; 95% CI, 0.53-3.26; P = .55), and stroke or death (OR, 0.85; 95% CI, 0.39-1.82; P = .68). Stroke or death at 1 year among asymptomatic patients was higher for redo CEA (hazard ratio [HR], 1.36; 95% CI, 1.08-1.69; P = .009) but was similar among symptomatic patients (HR, 0.94; 95% CI, 0.67-1.31; P = .71). CONCLUSIONS AND RELEVANCE: The outcomes of redo CEA and primary CEA fall within the professional guidelines for carotid revascularization. However, redo CEA is associated with a 2.8 times increase in the risk of stroke and a 2.2 times increase in the risk of death compared with primary CEA among asymptomatic patients. There is no significant difference in outcomes among symptomatic patients. These redo CEA and primary CEA results should inform patient and clinician expectations at the point of care. QUESTION: What are the risks associated with redo carotid endarterectomy relative to primary carotid endarterectomy? FINDINGS: In this cohort study of 64 118 carotid endarterectomies, redo carotid endarterectomy was associated with a 2.8 times increase in stroke and a 2.2 times increase in death among asymptomatic patients. There were no differences in outcomes among symptomatic patients. MEANING: These redo carotid endarterectomy and primary carotid endarterectomy results should inform patient and clinician expectations at the point of care. This cohort study evaluates the risks of redo carotid endarterectomy relative to primary carotid endarterectomy.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Arhuidese IJ, Faateh M, Nejim BJ, et al. Risks Associated With Primary and Redo Carotid Endarterectomy in the Endovascular Era. JAMA Surg. 2018. PMID: 29117272. doi:10.1001/jamasurg.2017.4477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。